Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast

OSUWexnerbloglogo2014 Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast. Here in the United States, the incidence of hepatocellular carcinoma is rising. The way that we approach cancer of the liver has changed over the past 20 years and today on MedNet, we are going to bring you up to date on the epidemiology, screening, diagnosis, and treatment of hepatocellular carcinoma. Joining us today is hepatologist and Assistant Professor of Internal Medicine, Dr. Lanla F. Conteh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the epidemiology of hepatocellular carcinoma in the United States; and RECOGNIZE which patients should be screened for hepatocellular carcinoma.

You’ll also learn about the following:

  • The rising incidence of hepatocellular carcinoma
  • New directions in treatment of hepatocellular carcinoma
  • Imaging test of choice in suspected hepatocellular carcinoma
  • How to biopsy suspected hepatocellular carcinoma
  • Viral hepatitis risk factors for hepatocellular carcinoma
  • Fibrolamellar hepatocellular carcinoma

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Pulmonary Hypertension

OSUWexnerbloglogo2014 CME Webcast Discusses Pulmonary Hypertension. Today on MedNet, we’re going to review the causes and diagnosis of pulmonary hypertension as well as the currently available treatments. On this CME webcast, in the studio, are pulmonary hypertension specialists from the Ohio State University. Dr. Shaun Smith is a pulmonologist and Assistant Professor of Internal Medicine. And Dr. Veronica Franco is a cardiologist and Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: PROVIDE basic determination if a patient may respond to calcium channel blockers for treatment of pulmonary hypertension; DETERMINE when a patient should be started on parental prostacyclins; DISCUSS the hemodynamic definition, classification and epidemiology of pulmonary arterial hypertension; and REVIEW the signs and symptoms of pulmonary arterial hypertension as well as the diagnostic algorithm.

You’ll also learn about the following:

  • The causes of pulmonary hypertension
  • Which patients should be treated with vasodilators
  • Vasodilator testing during the right heart cath
  • Selecting the right drug
  • Which patients do not benefit by vasodilators?
  • Anticoagulation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Sleep-Heart Interactions on CME Webcast

OSUWexnerbloglogo2014 Learn About Sleep-Heart Interactions on CME Webcast. The interactions between sleep disorders and heart disease are complex and today on MedNet, we’re going to unravel some of that complexity. Joining us in the studio is pulmonologist, sleep specialist, and Professor of Internal Medicine, Dr. Rami Khayat.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the mechanism of vascular disease in OSA; and DISCUSS the results of recent trials in the treatment of SDB.

You’ll also learn about the following:

  • The relationship between sleep disorders and cardiovascular disorders
  • Epidemiology of obstructive sleep apnea
  • Office-based screening for sleep apnea
  • Screening sleep studies in patients with cardiovascular disease
  • New methods for sleep apnea testing
  • Clues from the 24-hour blood pressure study
  • CPAP versus BiPAP
  • New devices for home non-invasive ventilation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Understanding the Management of Depression

OSUWexnerbloglogo2014 Understanding the Management of Depression. We now have more and better medications to treat depression than the anti-tuberculosis drug created in the 1950’s. We also have much better ways to screen and identify patients with depression. We’re pleased to welcome our guests today to tell us about depression in primary care. Dr. Nazhat Taj-Schaal is an Assistant Professor of Internal Medicine in the Division of General Internal Medicine and Kelli Barnes is a pharmacist and Assistant Professor in the College of Pharmacy.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW recent updated clinical guidelines that address screening for depression, monitoring treatment effects, and integration of behavioral health into primary care; and REVIEW medication treatment options, their unique characteristics and how to choose between different therapies.

You’ll also learn about the following:

  • Epidemiology of depression
  • Different antidepressants have different properties
  • Managing depressed patients in a busy primary care practice
  • Identifying the suicidal patient
  • Practical approach to antidepressant selection
  • Setting realistic expectations for antidepressant effects

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Provides a Thyroid Update

OSUWexnerbloglogo2014 CME Webcast Provides a Thyroid Update. Overall, 20 million Americans have some form of thyroid disease and over their lifetimes, 1 out of every 8 women will develop a thyroid disease. On this CME webcast, we’re going to hear about the spectrum of thyroid disorders. Joining our moderator in the studio is endocrinologist and Assistant Professor of Internal Medicine, Dr. Elizabeth Buschur.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the diagnosis and management of hypo- and hyperthyroidism; DIAGNOSE and manage a thyroid nodule.

You’ll also learn about the following:

  • Risk factors for thyroid disease
  • Epidemiology of thyroid disease
  • Thyroid storm
  • Myxedema coma
  • Choosing a thyroid replacement product
  • Over-the-counter animal thyroid replacement
  • Thyroid drug interactions
  • T3 levels, thyroglobulin antibodies, and thyroid peroxidase antibodies
  • Approach to the incidental goiter

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.